跳至主要内容
临床试验/NCT01131832
NCT01131832已完成4 期

Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

University of Manitoba4 个研究点 分布在 2 个国家目标入组 71 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
71
试验地点
4
主要终点
Serum Lipids

研究概览

简要总结

The substantial range of individual responsiveness to plant sterols has important ramifications. Marked differences across individuals in particular aspects of the cholesterol metabolic pathway must alter the impact of plant sterol consumption. As such, a pronounced need exists to understand the genetic and metabolic factors that explain the substantial degree of heterogeneity in response of lipid concentrations to plant sterols across individuals. The primary focus of this trial is to delineate the impact of differing cholesterol synthesis levels on response of LDL-C and other plasma lipids to plant sterol consumption. Participants pre-identified as high or low endogenous cholesterol synthesizers, according to their screening level of lathosterol to cholesterol ratios, will be given PS or a placebo containing margarine to consume under supervision for 4 weeks in a crossover design. The trial will characterize the responsiveness of the participants' total, LDL, and HDL cholesterol, as well as triacylglycerol (TG) concentrations, to plant sterol consumption. This research will determine if cholesterol synthesis phenotype predicts the responsiveness of lipids to plant sterol consumption. Variations in candidate genes involved in cholesterol metabolism will also be investigated in order to find associations with both cholesterol metabolism phenotypes and responsiveness of lipids to plant sterols. The output of this research will be to advance the knowledge of which genetic factors influence the degree of cardiovascular benefit derived from plant sterols through lipid lowering.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fasting serum LDL cholesterol >3.0 mmol/L
  • high or low lathosterol to cholesterol ratio

排除标准

  • use of lipid lowering therapy
  • documented cardiovascular/atherosclerotic disease
  • inflammatory disease
  • uncontrolled hypertension
  • kidney disease
  • liver disease
  • other systemic diseases
  • chronic alcohol consumption (> 2 servings/day)

结局指标

主要结局

Serum Lipids

时间窗: Baseline (Day 1,2) and Endpoint (Day 27,28) of each experimental period

Total Cholesterol, LDL-C, HDL-C, Triglycerides

Serum non-cholesterol sterols

时间窗: Baseline (Day 1,2) and Endpoint (Day 27,28) of each experimental period

Lathosterol,Lanosterol,Desmosterol,Sitosterol,Campesterol,Cholestanol,

Genotype via single nucleotide polymorphism analysis

时间窗: Baseline

SNP genotyping in genes related to cholesterol metabolism

次要结局

  • Cholesterol synthesis measurement by deuterium incorporation(Endpoint (Day 27,28) of each experimental period)
  • Change in cholesterol absorption due to plant sterol consumption(Change in cholesterol absorption from control period (measured over days 24-28) to plant sterol period (days 24-28))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Peter J. H. Jones

Professor, Food Science and Human Nutritional Sciences

University of Manitoba

研究点 (4)

Loading locations...

相似试验

Genetic Basis for Heterogeneity in Response of... | 临床试验